Originally Posted by Anonymous
LabCorp had even told many of their people that they were going to buy Carilion so its going to be interesting to see who buy Solstas in the end when WCAS wants to get their money out. I bet that they already have offers from both LabCorp and Quest but WCAS are holdiong out for more money and to determine what company that they want to buy and sell next for a lot of money.
It will be interesting. Solstas is simply trying to stabilize itself at this point. The rapid flurry of buyouts has stopped and the footprint is pretty well set. Solstas has aligned its Operations to mirror a Quest or Labcorp to make itself more attractive from an ease of integration aspect.
Solstas has ALOT of operational fat that either QDX or LCA will look to trim immediately. Probably 20% of phlebotomists will be pulled out of offices in the first 6 months after takeover.